Interhospital transportation of a COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation by helicopter.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
May 2021
Historique:
received: 01 08 2020
revised: 28 09 2020
accepted: 30 09 2020
pubmed: 18 10 2020
medline: 12 5 2021
entrez: 17 10 2020
Statut: ppublish

Résumé

Some coronavirus disease 2019 (COVID-19) patients develop rapidly progressive acute respiratory distress syndrome and require veno-venous extracorporeal membrane oxygenation (V-V ECMO). A previous study recommended the transfer of ECMO patients to ECMO centers. However, because of the pandemic, a limited number of ECMO centers are available for patient transfer. The safe long-distance interhospital transport of these patients is a concern. To minimize transportation time, helicopter use is a suitable choice. We report the first case of a COVID-19 patient on V-V ECMO, transferred to our ECMO center by helicopter. A 45-year-old man with rheumatoid arthritis history, treated with immunosuppressants, presented with fever and sore throat. He was diagnosed with COVID-19 following a positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test result and was subsequently prescribed favipiravir. However, his respiratory failure progressively worsened. On day 10 of hospitalization at the previous hospital, he was intubated, and we received a request for ECMO transport on the next day. The ECMO team, who wore personal protective equipment (N95 respirators, gloves, gowns, and face shields), initiated V-V ECMO in the referring hospital and safely transported the patient by helicopter. The flight time was 7 min. He was admitted to the intensive care unit of our hospital and received tocilizumab. He was discharged on hospital day 31 with no significant sequelae. In this case report, we discuss important factors for the safe and appropriate interhospital transportation of COVID-19 patients on ECMO as well as staff and patient safety during helicopter transportation.

Identifiants

pubmed: 33067063
pii: S0735-6757(20)30885-8
doi: 10.1016/j.ajem.2020.09.089
pmc: PMC7836635
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

290.e5-290.e7

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflicts of interest to report.

Références

Crit Care. 2020 May 6;24(1):198
pubmed: 32375845
Lancet Respir Med. 2020 May;8(5):518-526
pubmed: 32203711
Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901
pubmed: 25695688
Can J Anaesth. 2020 May;67(5):568-576
pubmed: 32052373
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Cleve Clin J Med. 2020 Jun 9;:
pubmed: 32518133
Scand J Trauma Resusc Emerg Med. 2020 May 25;28(1):43
pubmed: 32450877
Lancet. 2009 Oct 17;374(9698):1351-63
pubmed: 19762075

Auteurs

Taro Imaeda (T)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Noriyuki Hattori (N)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: hat@chiba-u.jp.

Ryuzo Abe (R)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: ryuzoabe@chiba-u.jp.

Shinya Iwase (S)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Daiki Saito (D)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Kazuhisa Koizumi (K)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Wansiri Chaisirin (W)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Toshibumi Taniguchi (T)

Department of Infectious Diseases, Chiba University Hospital, Chiba, Japan. Electronic address: tosh-tanig@chiba-u.jp.

Taka-Aki Nakada (TA)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: taka.nakada@nifty.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH